Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: The Third International Symposium on the Molecular Biology of Breast Cancer

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy

MK Schmidt, TC van Sprundel, MA Rookus, R Brohet, CJ van Asperen, EJTh Rutgers, RAEM Tollenaar and LJ van 't Veer

Breast Cancer Research 2005, 7(Suppl 2):P1.09 doi:10.1186/bcr1096

Accesses  

  • Last 30 days: 9 accesses
  • Last 365 days: 112 accesses
  • All time: 1009 accesses